Skip to content
value.today
Total raised
$108 M
4 rounds on record
Latest round
$37 M
Dec 2024
First round on record
Dec 2015
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of bioMASON Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2024$37 MNo. 4$10 to $50 million

bioMASON Inc.: Raise no. 4, Dec 2024

Investors in this round

6 investors had bought by the notice of Jan 3, 2025: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$37 M of $51 M offered; $14 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Camilo Restrepo · Executive Officer, Director
  • Lily Wachter · Executive Officer
  • Anders Spohr · Director
  • Bradley Knight · Director
  • Michael Marks · Director
  • Michael Noel · Director
  • Niels Christian von Luttichau Jolck · Director
  • Peder Holk-Nielsen · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “$20,838,687 of each of the Total Offering Amount and the Total Amount Sold came from the conversion of existing convertible notes.”
  • On the use of proceeds: “None other than payments of salary and bonus amounts in the ordinary course of business.”

Signed by Camilo Restrepo, Chief Executive Officer. Source: SEC Form D, newest notice filed Jan 3, 2025. Read the notice at the SEC.

equitySEC
Feb 2022$65 MNo. 3$50 to $250 million

bioMASON Inc.: Raise no. 3, Feb 2022

Investors in this round

8 investors had bought by the notice of Feb 28, 2022: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$65 M of $65 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Ginger K. Dosier · Executive Officer, Director
  • Anders Bendsen Spohr · Director
  • Bradley Falvig Knight · Director
  • Michael Christian Von Luttichau Marks · Director
  • Michael F. Noel · Director
  • Michael Falvig Petro · Director
  • Niels Christian Von Luttichau Jolck · Director
  • Ole Falvig Ramsby · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “None other than payments of salary and bonus amounts in the ordinary course of business.”

Signed by Ginger K. Dosier, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Feb 28, 2022. Read the notice at the SEC.

equitySEC
Nov 2019$5 MNo. 2$2 to $10 million

bioMASON Inc.: Raise no. 2, Nov 2019

Investors in this round

1 investor had bought by the notice of Dec 9, 2019: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $18 M offered; $13 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Ginger M. Dosier · Executive Officer, Director
  • Anders M. Spohr · Director
  • Michael F. Noel · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Total offering amount excludes conversion of outstanding convertible indebtedness.”
  • On the use of proceeds: “None other than payments of salary and bonus amounts in the ordinary course of business to certain of the parties named in response to Item 3.”

Signed by Ginger M. Dosier, Chief Executive Officer. Source: SEC Form D, newest notice filed Dec 9, 2019. Read the notice at the SEC.

equitySEC
Dec 2015$2 MNo. 1Under $2 million

bioMASON Inc.: Raise no. 1, Dec 2015

Investors in this round

3 investors had bought by the notice of Dec 22, 2015: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $3 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Ginger K. Dosier · Executive Officer, Director
  • John M. Dosier · Executive Officer
  • Michael F. Noel · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “None other than payments of salary in the ordinary course of business to certain of the parties named in response to Item 3.”

Signed by Merrill M. Mason, Attorney-in-fact. Source: SEC Form D, newest notice filed Dec 22, 2015. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • bioMASON Inc. chose not to state its revenue in its newest notice of a funding round (Jan 2025).

    SEC Form D · Jan 2025

  • The industry group it chose in its notices: Other.

    SEC Form D · Jan 2025

That is all the official record says: bioMASON Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of bioMASON Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 8 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by bioMASON Inc.
NameRoleNamed in
Camilo RestrepoExecutive officerJan 2025
Lily WachterExecutive officerJan 2025
Ginger K. DosierExecutive officerFeb 2022
Ginger M. DosierExecutive officerDec 2019
John M. DosierExecutive officerDec 2015
Anders SpohrDirectorJan 2025
Bradley KnightDirectorJan 2025
Camilo RestrepoDirectorJan 2025
Michael MarksDirectorJan 2025
Michael NoelDirectorJan 2025
Niels Christian von Luttichau JolckDirectorJan 2025
Peder Holk-NielsenDirectorJan 2025
Anders Bendsen SpohrDirectorFeb 2022
Bradley Falvig KnightDirectorFeb 2022
Ginger K. DosierDirectorFeb 2022
Michael Christian Von Luttichau MarksDirectorFeb 2022
Michael F. NoelDirectorFeb 2022
Michael Falvig PetroDirectorFeb 2022
Niels Christian Von Luttichau JolckDirectorFeb 2022
Ole Falvig RamsbyDirectorFeb 2022
Anders M. SpohrDirectorDec 2019
Ginger M. DosierDirectorDec 2019